About Us

Letter from the CEO Business Overview Business History Core Networks C.I Introduction

Letter from the CEO

HOME > About us > Letter from the CEO

CEO
Mi Won SOHNCEO of MTHERA PHARMA

Hello, everyone.
Welcome to our website!
This is Mi Won SOHN, CEO of MTHERA PHARMA.

MTHERA PHARMA was established in February 2020. By collaborating with world renowned scholars of Korea, we developed expertise in multi-component and multi-targeting (MCMT) approach and cutting-edge CMC technology.

We strive to be a more global pharmaceutical R&D company by pursuing health and happiness of mankind through development of new medicine for chronic diseases.

We look forward to your support and attention. Thank you.

Hello, everyone.
Welcome to our website!
This is Mi Won SOHN, CEO of MTHERA PHARMA.

MTHERA PHARMA was established in February 2020.
By collaborating with world renowned scholars of Korea,
we developed expertise in multi-component and
multi-targeting (MCMT) approach and cutting-edge CMC technology.

We strive to be a more global pharmaceutical R&D company
by pursuing health and happiness of mankind
through development of new medicine for chronic diseases.

We look forward to your support and attention.

Thank you.

CEO
Mi Won SOHNCEO of MTHERA PHARMA

Who is the CEO?

Profile

Graduated College of Pharmacy, Seoul National University
Vice President, Dong-A Pharm, Dong-A ST
Director, Global Botanical Drug Development Center of Ministry of Trade, Industry, and Energy
Vice President, Helixmith

Roles in Public Policy

Member, Presidential Advisory Council on Science and Technology
Expert Advisor, Committee of Government’s R&D Policy and Health Technology
Board Member, Bio-Synergy Research Center
Industry member, National Biodiversity Committee, Ministry of Environment

Professional Association

Chair of the Industrial-Academic Cooperation Committee of the Pharmaceutical Society of Korea
Vice Chair of the Korean Society of Applied Pharmacology
Vice Chair of the Korean Society of Pharmacognosy
Vice Chair of the Korean Association of Herbal Medicinal Products

Product Development

Domestic

Stillen(No. 1 natural product in sales, the highest annual sales of 90 billion): Pharmacological research
Motilitione(gastrointestinal simulator, over 20 billion): Research Director

Global

DA-9801(Diabetic neuropathy treatment, US phase 2 clinical success): Head of development
DA-9805(Parkinson’s treatment, US phase 3 clinical trial): Head of development
DA-9803(Dementia treatment, global clinical research): Head of development

Awards & Honors

2017. 12. 20 “Woman Scientist of The Year” (Ministry of Science and ICT)
2016. 05. 19 Presidential Citation(Ministry of Environment)
2015. 10. 29 IR52 Jang Young-Shil Award (Ministry of Science and ICT)